The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics

Abroad (travel likely)Recruiting

Conditions

Pulmonary Embolism

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Juhong Shi, M.D) · shijh@pumch.cn · +8613701178492
Contact: Study coordinator (Min Peng, M.D) · pengmin@pumch.cn · +8613581888792

Study leads

Juhong Shi, M.D
Principal Investigator
Peking Union Medical College Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing

Venous Thromboembolism · Deep Vein Thrombosis · Pulmonary Embolism

Abroad (travel likely)RecruitingPHASE3

Agen, France · Angers, France

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Pulmonary Embolism · Embolism · Embolism and Thrombosis

Abroad (travel likely)RecruitingPHASE4

Woluwe-Saint-Lambert, Belgium · Liège, Belgium

A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism

Acute Pulmonary Embolism

Abroad (travel likely)Recruiting

Guangzhou, China

Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)

Pulmonary Embolism

Abroad (travel likely)RecruitingPHASE3

Copenhagen, Denmark · Odense, Denmark